Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system.
about
Genomic diversity among drug sensitive and multidrug resistant isolates of Mycobacterium tuberculosis with identical DNA fingerprintsFirst evaluation after implementation of a quality control system for the second line drug susceptibility testing of Mycobacterium tuberculosis joint efforts in low and high incidence countriesReevaluation of the critical concentration for drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide using wild-type MIC distributions and pncA gene sequencing.Outbreak of pyrazinamide-monoresistant tuberculosis identified using genotype cluster and social media analysis.Potential for erroneous results indicating resistance when using the Bactec MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamideSurveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand.Multicenter laboratory validation of the BACTEC MGIT 960 technique for testing susceptibilities of Mycobacterium tuberculosis to classical second-line drugs and newer antimicrobials.Evaluation of two molecular assays for rapid detection of mycobacterium tuberculosis resistance to fluoroquinolones in high-tuberculosis and -multidrug-resistance SettingsDirect drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter studyComparative evaluation of Löwenstein-Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosisDevelopment and evaluation of a line probe assay for rapid identification of pncA mutations in pyrazinamide-resistant mycobacterium tuberculosis strains.Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strainsMulticenter evaluation of the MB/BACT system for susceptibility testing of Mycobacterium tuberculosisEvaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method.Evaluation of methods for testing the susceptibility of clinical Mycobacterium tuberculosis isolates to pyrazinamide.Correlation between pyrazinamide activity and pncA mutations in Mycobacterium tuberculosis isolates in Taiwan.Evolution of central nervous system multidrug-resistant Mycobacterium tuberculosis and late relapse of cryptic prosthetic hip joint tuberculosis: complications during treatment of disseminated isoniazid-resistant tuberculosis in an immunocompromisedUsefulness of the GenoType MTBC assay for differentiating species of the Mycobacterium tuberculosis complex in cultures obtained from clinical specimens.Pyrazinamide Susceptibility and pncA Mutation Profiles of Mycobacterium tuberculosis among Multidrug-Resistant Tuberculosis Patients in Bangladesh.Drug-susceptibility testing in TB: current status and future prospects.Pyrazinamide Resistance among Multidrug-Resistant Mycobacterium tuberculosis Clinical Isolates in Myanmar.
P2860
Q28476294-184CA940-6919-47E9-832C-30E328FBEEADQ28534345-E52260B3-8CB6-4C63-AA0A-AC24928FD5CDQ30224832-AD08288F-A8B0-471F-8D06-6B3E4021BA80Q30405961-86CDE35D-DA7D-48E3-914C-1D2CF515EDA2Q33614112-31A97E3A-68D0-4189-937C-F363AD9257B3Q33667486-8AEB864C-F00D-4A79-B751-CA3DB49F3DAFQ34431814-FFB81D09-0E9E-49CB-A70F-297DA3F16688Q35139804-7BFF4735-6B94-4B73-89FA-3E49AEEDA89CQ35688986-6A69FF88-A3B7-4062-867C-828F8B8DCB44Q35690257-9E1B77F7-A77A-477D-BB4F-44B0BFBCF80AQ36098662-BF139A37-4E23-41D1-9130-E6E668CA294EQ36359595-4FAA21D1-A94D-4C64-9FB2-441FC8DB1D06Q36413991-9B6B1430-CE5D-4F21-9CED-42D02A8A5086Q36600075-9E4A9F14-FD80-4768-AF5C-AF297969B118Q36600112-600FDDE2-B35A-4C01-A2EE-0626E4F0EAC8Q36826734-4D19FF01-B666-478F-B37E-019616FFE7C2Q36880482-1793C769-7B20-4275-BEE4-10DC811A2FBDQ37099576-7D15F82F-7DBC-4F7E-A791-94AD8E1A6F02Q37511164-8289A8B0-62E7-47F4-BA43-E41E56142A0EQ38718396-ED347472-A46B-405C-87CE-5C061B078448Q39872573-2F2FE067-B27E-4991-8864-5615A0256606Q53714526-05369E5B-89EF-4D3C-80C0-63707EB7C0B4
P2860
Testing of susceptibility of Mycobacterium tuberculosis to pyrazinamide with the nonradiometric BACTEC MGIT 960 system.
description
2002 nî lūn-bûn
@nan
2002 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Testing of susceptibility of M ...... metric BACTEC MGIT 960 system.
@ast
Testing of susceptibility of M ...... metric BACTEC MGIT 960 system.
@en
Testing of susceptibility of M ...... metric BACTEC MGIT 960 system.
@nl
type
label
Testing of susceptibility of M ...... metric BACTEC MGIT 960 system.
@ast
Testing of susceptibility of M ...... metric BACTEC MGIT 960 system.
@en
Testing of susceptibility of M ...... metric BACTEC MGIT 960 system.
@nl
prefLabel
Testing of susceptibility of M ...... metric BACTEC MGIT 960 system.
@ast
Testing of susceptibility of M ...... metric BACTEC MGIT 960 system.
@en
Testing of susceptibility of M ...... metric BACTEC MGIT 960 system.
@nl
P2093
P2860
P1476
Testing of susceptibility of M ...... metric BACTEC MGIT 960 system.
@en
P2093
Frantiska Palicova
Gaby E Pfyffer
Sabine Rüsch-Gerdes
P2860
P304
P356
10.1128/JCM.40.5.1670-1674.2002
P407
P577
2002-05-01T00:00:00Z